{"ticker": {"uuid": "c0c15a1d-bf51-4a51-a718-f08f9863cbd0", "symbol": "RKDA", "name": "Arcadia Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Consumer Defensive", "industry": "Packaged Foods"}, "articles": [{"title": "Arcadia Biosciences (RKDA) registers 11.9M resale shares from 2026 private placement", "summary": "Arcadia Biosciences is registering 11.9 million shares of common stock for resale by existing stockholders, which are issuable upon the exercise of pre-funded warrants, preferred investment options, and placement agent options from a private placement completed in June 2026. The ", "url": "https://www.stocktitan.net/sec-filings/RKDA/424b3-arcadia-biosciences-inc-prospectus-filed-pursuant-to-rule-424-b-14ba1909ac94.html", "source_name": "Stock Titan", "published_at": "2026-07-09T10:31:13", "published_display": "09 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Arcadia Biosciences, Inc. SEC Filing", "summary": "This article reports on an SEC filing by Arcadia Biosciences, Inc. (RKDA), detailing a Notice of Effectiveness for an S-3 form with an effectiveness date of July 8, 2026, at 5:00 P.M. The filing indicates a neutral impact and sentiment. The article also provides an overview of RK", "url": "https://www.stocktitan.net/sec-filings/RKDA/effect-arcadia-biosciences-inc-sec-filing-3a613fcdead2.html", "source_name": "Stock Titan", "published_at": "2026-07-09T10:31:13", "published_display": "09 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Arcadia Biosciences, Inc. \u2013 NASDAQ:RKDA", "summary": "The article focuses on the \"Price to sales forward\" metric for Arcadia Biosciences, Inc. (NASDAQ: RKDA). It is presented as a financial data point available on TradingView, within the company's financial overview. The content primarily highlights the financial metric without prov", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T18:40:12", "published_display": "04 Jul 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Arcadia Biosciences, Inc. \u2013 NASDAQ:RKDA", "summary": "This article displays the \"Price to earnings forward\" financial metric for Arcadia Biosciences, Inc. (NASDAQ: RKDA). It indicates that there are currently no trades and the market is closed for this stock. The content appears to be a stub or a placeholder from a financial data pl", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T09:10:54", "published_display": "04 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RKDA SEC Filings - Arcadia Bioscien 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Arcadia Biosciences (RKDA) SEC filings, including 10-K, 10-Q, and 8-K reports. It details recent material events such as the CFO's resignation and the CEO taking an interim finance role, as well as financial disclosures from Q2 2025", "url": "https://www.stocktitan.net/sec-filings/RKDA/page-3.html", "source_name": "Stock Titan", "published_at": "2026-07-04T06:09:55", "published_display": "04 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (FRA:17D) - Valuation Measures & Financial Statistics", "summary": "This article provides key valuation measures and financial statistics for Arcadia Biosciences Inc (FRA:17D) as of July 3. The company is currently operating at a loss with a P/B ratio of 0.52 and a market capitalization of \u20ac1.40M. It also highlights four severe warning signs dete", "url": "https://www.gurufocus.com/stock/DE00AZ/definition", "source_name": "GuruFocus", "published_at": "2026-07-04T05:10:54", "published_display": "04 Jul 2026 05:10", "sentiment": "negative", "sentiment_pct": 25, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences focuses on plant-based innovation for future growth", "summary": "Arcadia Biosciences is a biotechnology company focused on plant-based science for health, nutrition, and agriculture. The company aims to create long-term value through innovation in crops and plant-derived compounds, emphasizing intellectual property, strategic product developme", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/arcadia-biosciences-focuses-on-plant-based-innovation-for-future-growth/69680378", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T14:09:12", "published_display": "03 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences awards discretionary bonus to Thomas J. Schaefer", "summary": "Arcadia Biosciences approved a discretionary cash bonus for Thomas J. Schaefer, its CEO and Interim CFO, for his services in 2025. The bonus amount is $169,000, and it was approved by the Board and Compensation Committee. This announcement also noted the resignation of former CFO", "url": "https://www.tradingview.com/news/tradingview:1582148cf697c:0-arcadia-biosciences-awards-discretionary-bonus-to-thomas-j-schaefer/", "source_name": "TradingView", "published_at": "2026-07-02T20:40:32", "published_display": "02 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 58, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (NASDAQ: RKDA) grants CEO bonus and sets 2026 vote deadlines", "summary": "Arcadia Biosciences (NASDAQ: RKDA) has updated its executive compensation, awarding CEO Thomas J. Schaefer a discretionary cash bonus of $169,000 for 2025, bringing his total compensation to $473,058. The company also announced that its 2026 annual meeting of stockholders will be", "url": "https://www.stocktitan.net/sec-filings/RKDA/8-k-arcadia-biosciences-inc-reports-material-event-d9467e85dc6a.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:32", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences | 424B3: Prospectus", "summary": "This document is a 424B3 prospectus filing for Arcadia Biosciences. A prospectus is a formal legal document that is required by and filed with the SEC, providing details about an investment offering for sale to the public.", "url": "https://www.moomoo.com/news/notice/306473753/arcadia-biosciences-424b3-prospectus", "source_name": "Moomoo", "published_at": "2026-06-28T04:09:39", "published_display": "28 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-3 Arcadia Biosciences Inc For: 26 June", "summary": "This article announces the filing of Form S-3 by Arcadia Biosciences Inc. for June 26. It includes a standard Investing.com disclaimer about the high risks associated with trading financial instruments and cryptocurrencies, emphasizing that the data provided may not be real-time ", "url": "https://m.uk.investing.com/news/stock-market-news/form-s3-arcadia-biosciences-inc-for-26-june-93CH-4746945?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-27T04:09:21", "published_display": "27 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Arcadia Biosciences, Inc. \u2013 NASDAQ:RKDA", "summary": "This article displays the \"Enterprise value to revenue forward\" metric for Arcadia Biosciences, Inc. (NASDAQ: RKDA) on TradingView. It indicates that the market was closed at the time of viewing, with no trades activity. The content specifically highlights the financial metric fo", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:40:39", "published_display": "27 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) registers 11.9M shares for resale; options convertible", "summary": "Arcadia Biosciences (RKDA) has filed an S-3 registration statement for the resale of up to 11.9 million shares of common stock, which are issuable upon the exercise of pre-funded warrants, preferred investment options, and placement agent options. The company will not receive pro", "url": "https://www.stocktitan.net/sec-filings/RKDA/s-3-arcadia-biosciences-inc-shelf-registration-statement-91314cce39dc.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:40:39", "published_display": "26 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Actuals & Estimates (NASDAQ:RKDA)", "summary": "This article provides an overview of Arcadia Biosciences, Inc. (NASDAQ: RKDA) stock performance, financial actuals, and estimates. It covers current stock price, market capitalization, volatility, past earnings, and upcoming earnings reports, along with other financial metrics an", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:09:21", "published_display": "26 Jun 2026 15:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Actuals & Estimates (GETTEX:17D)", "summary": "This article provides an overview of Arcadia Biosciences, Inc. (GETTEX:17D), including its current stock price, market capitalization, and historical performance. It details financial actuals and estimates, such as earnings and revenue, and notes upcoming earnings report dates. T", "url": "https://www.tradingview.com/symbols/GETTEX-17D/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:39:38", "published_display": "25 Jun 2026 21:39", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Arcadia Biosciences Inc (RKDA) has a current financial score of 6.21, ranking 75 out of 95 in the Food & Tobacco industry, indicating a robust financial status despite low operating efficiency. The company's latest quarterly revenue was $1.10M, an 8.33% year-over-year decrease, a", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/financial-health", "source_name": "TradingKey", "published_at": "2026-06-23T09:39:29", "published_display": "23 Jun 2026 09:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Valuation: PE, PB & Fair Value Analysis", "summary": "Arcadia Biosciences Inc (RKDA) currently holds a valuation score of 8.65, placing it 37th out of 95 companies in the Food & Tobacco industry as of June 18, 2026. The company's P/E ratio is -0.14, which is significantly below its recent high and above its recent low. Key valuation", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-20T00:38:54", "published_display": "20 Jun 2026 00:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Arcadia Biosciences Inc (RKDA), detailing analyst ratings, price targets, and future revenue and EPS expectations. It notes that no earnings forecast score is currently available, but highlights a consensus \"Buy\" rating from one analy", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T13:09:09", "published_display": "19 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Arcadia Biosciences Inc (RKDA), highlighting its current price momentum score of 6.42 and identifying resistance at 1.56 and support at 0.38. Technical indicators, including MACD, RSI, and CCI, largely suggest a \"Sell\" signal, while a", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/technical", "source_name": "TradingKey", "published_at": "2026-06-19T11:09:09", "published_display": "19 Jun 2026 11:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Arcadia Biosciences Inc (RKDA), highlighting regional revenue contribution with specific figures for the United States at $4.86 million. It notes that relevant data for business segments, India, Canada, and Argentina have not yet been", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T01:39:43", "published_display": "17 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "summary": "Arcadia Biosciences (RKDA) has announced a private placement totaling $4 million through the sale of common stock and preferred investment options. The offering, priced at-the-market under Nasdaq rules, is expected to close around June 12, 2026, with proceeds intended for working", "url": "https://www.globenewswire.com/news-release/2026/06/12/3310862/35730/en/arcadia-biosciences-rkda-announces-4-million-private-placement-priced-at-the-market-under-nasdaq-rules.html", "source_name": "GlobeNewswire", "published_at": "2026-06-16T04:39:41", "published_display": "16 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Raises ~$4 Million in Private Placement of Pre-Funded Warrants and Options", "summary": "Arcadia Biosciences announced a private placement raising approximately $4 million from an institutional accredited investor through the issuance of pre-funded warrants and Series A-1 and A-2 preferred investment options. The company also signed a registration rights agreement to", "url": "https://www.tradingview.com/news/tradingview:fc209fbef1708:0-arcadia-biosciences-raises-4-million-in-private-placement-of-pre-funded-warrants-and-options/", "source_name": "TradingView", "published_at": "2026-06-15T15:10:24", "published_display": "15 Jun 2026 15:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) completes $4M private placement with warrants and options", "summary": "Arcadia Biosciences (RKDA) has completed a $4 million private placement, issuing pre-funded warrants and Series A-1 and A-2 preferred investment options to an institutional accredited investor. The transaction, priced at $1.03 per unit under", "url": "https://www.stocktitan.net/sec-filings/RKDA/8-k-arcadia-biosciences-inc-reports-material-event-b5278ecbcc63.html", "source_name": "Stock Titan", "published_at": "2026-06-15T15:10:24", "published_display": "15 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million", "summary": "Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced a private placement aiming to raise around $4 million. The offering includes common stock and preferred stock options, with the proceeds intended for working capital and general corporate purposes. This strategic move is expected", "url": "https://www.moomoo.com/news/post/71455586/arcadia-biosciences-inc-announces-private-placement-of-common-stock-and", "source_name": "Moomoo", "published_at": "2026-06-15T07:09:36", "published_display": "15 Jun 2026 07:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "summary": "Arcadia Biosciences, Inc. (Nasdaq: RKDA) has announced the closing of a $4 million private placement. The placement involved the sale of common stock or pre-funded warrants, along with Series A-1 and A-2 preferred investment options, priced at $1.03 per share under Nasdaq rules, ", "url": "https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/arcadia-biosciences-rkda-announces-closing-of-4-million-private-placement-priced-at-the-market-under-nasdaq-rules/2364775", "source_name": "The Manila Times", "published_at": "2026-06-15T07:09:36", "published_display": "15 Jun 2026 07:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "summary": "Arcadia Biosciences (RKDA) announced a private placement of 4 million shares of its common stock to institutional investors, priced at $1.00 per share, resulting in gross proceeds of $4 million. The offering is expected to close around December 13, 2024, and the company plans to ", "url": "https://www.moomoo.com/news/post/71417410/press-release-arcadia-biosciences-rkda-announces-4-million-private-placement?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-14T09:41:05", "published_display": "14 Jun 2026 09:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences closes $4 million private placement By Investing.com", "summary": "Arcadia Biosciences (NASDAQ:RKDA) has completed a private placement, raising approximately $4 million in gross proceeds. The company sold nearly 3.9 million shares of common stock or pre-funded warrants at $1.03 per share, which is significant given its current market capitalizat", "url": "https://ng.investing.com/news/stock-market-news/arcadia-biosciences-closes-4-million-private-placement-93CH-2557065", "source_name": "Investing.com Nigeria", "published_at": "2026-06-13T10:39:27", "published_display": "13 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOTFNWQlkxdkJKWS0xXzJpaTJqbTZOQUctVGVBVTF3cGRLRS1JTHR2YlFubHlyMGVibURDQWt4Rm8yWWxYVVQzcklCNFMwVlpjOURIZy1xR1MxNnJOSHlQRVU3ZXRuekk2UW1lcVhCdlJMbldvR1R5VzRrcDBoZlRFcEJyVjVKbVljNk1YRTVLTXI5UWZiR0NOZXczcWEzQUlrTTJ0QzZuN2o5d3ktY0dqY1RsS0JpeHAzZDdPNzNWQkk4LWdxcHB1RldTU0tSOV92ODByYjZZUHdRZHFfYzhmNg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences raises $4M in at-the-market stock deal", "summary": "Arcadia Biosciences (Nasdaq: RKDA) has closed a $4 million private placement, selling 3,883,496 common shares (or pre-funded warrants) and associated Series A-1 and A-2 preferred investment options at $1.03 per share. The net proceeds will be used for working capital and general ", "url": "https://www.stocktitan.net/news/RKDA/arcadia-biosciences-rkda-announces-closing-of-4-million-private-rviky4ef2bfc.html", "source_name": "Stock Titan", "published_at": "2026-06-13T02:10:15", "published_display": "13 Jun 2026 02:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Raises $4 Million in Private Placement", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/arcadia-biosciences-raises-4-million-072643946.html", "source_name": "MT Newswires", "published_at": "2026-06-12T07:26:43+00:00", "published_display": "12 Jun 2026 07:26", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences raises $4 million in private placement By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNSGVPQ2J6VTUtZTA0OXlFSGtKM1hFUGU2NHpON1BhNmNocnE4ZW9YaDY3ck1JRFZnZnNmWHUtZ0dQY01wdFkyY3FzZVVaRkxzS09aTThYQ1VZbXJYZUhiTVBJUTNpZGtQZkJZRFdld2xPSGUyTDBXc2pmWWRqVmVveFJSUkhrci0xV2MyOWVwZkIwaWdzdmNwWDI3V01BTkd4MlhQYkRsci1VNHRiZnVRMGhVY2QtWkxURHc?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-06-12T00:40:55+00:00", "published_display": "12 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wellness products maker Arcadia Biosciences lines up $4M in funding", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQaFhyRVY5V1paRlhRTnB6UFgzd1BMMmpxem5mZ1EteHV2T0M5MUpoSHZlblNKNUV4cnJGTFVBMldDSnFYNW9NcUFuT2VjaVVWSUpXcHk2cFowSVJpdnBfTm1mVFgxSlZoWHlZTVk4WVFCN3U3bmpzRllLY1RSRE94T2dzLUNkWll6SDQ4YTJzSG9HTDBCaFZRLXlLM2FyT2NKTlktbFp3aEFYRlZzWXhxVXVJZFBRcThV?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences stock (US03020Q1058): pipeline update and strategic shift keep investors watchin", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOX0Z2c0NlYm9sM1RPTFFUZVNLWS1fcmJGTkpGOTlGaU5LeUQ1TmMzOHhSQzNjX2ZvS2ZKZk5qcXZLYjU2c29vemk3dmR1SjJuWUtRSGtFRndEMWEzZktiY3RWLXRBS3I1dnktS2FWeG1tYlc2ekNkTS1TcnVMR01JM0pTTGt2V3Q4Q2RoOHE5UTBzOWU2WWI2WHdSUG9wNW5vWnBpdFVTYm0tZG45b1VtMzJaNVh2ZTJHbWNRS3I0VjJIVFlTd3c?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/arcadia-biosciences-q1-earnings-snapshot-230843698.html", "source_name": "Associated Press", "published_at": "2026-05-14T23:08:43+00:00", "published_display": "14 May 2026 23:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPcmU1OVdFZERha0pSdnh3Q0NhNG1HX3Y0TjR3UnRsMnBFMUF5ZU1JMU85emROc2YwRHVEWFV6Y1RoY1cwWVNaNEtRN0prUkxuV2E2UjdKdUZQY2tyOFBNSW4tVnBPNGxqemc4ODJaY1Nyc1Q0Wm9VN2VPSUctbXJCUGZOeEJEWTkzSGJoOUZJVVByc0UtSDRWUUVkU1NRQVJfa1R2bk1vZmlQbzNEVHk5c0lOSDRqODE0V3pHc09PQWRIZ196M1NNWnNFNklEN0RQRlBtQzFjZ0xlX2lpMnVWbFdmVy1lNlBqWjliOVBqQkNaV1VlQmRQdVBtWQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Bioscien (RKDA) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFB6bFZRQjRkcG1rODZxeFY0ZVk3UmdHVlJCWGJrYVRWTE1WMTRjSm4xRmY2UXVTQ3llY1gxQlQyNW5BOWQwQS1lOVVSenB1UQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxQNS0yVnF0QnhXZ3RCbVpIamlub3RiRjdrSl9Nc2Z2Q3FqY1c3QWpzTjhYdUEyM2tKUTM2NFZPdUoxRV8tU1JodzRjR3RqYlRuRkdiN1dYSXZoanBUUndFb2pzX1c2U19DYUhCMHF0N20yS1ZFYUNUTDhjXzRzTlZnSEJlWmphd3JoeUFnckdQd3dWcW1kcDBBU3JtLURVVnJDVEJERHFpNURzY0tveFctTVM0UFdtSXhZMXFSMFNHSTNyTzB1RFBZTjAxN1lfZ1oxVFpTSFRpeTgwZ3RBUkVUZmR6ZllucHkwazFYaGpmZGRmenpIRG1ZVEJPMHEtVFNKSC1saw?oc=5", "source_name": "Business Wire", "published_at": "2024-12-05T08:00:00+00:00", "published_display": "05 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOdS04bXkyZjFid1hiVjZsRXVwVnJDSjF4RFZWQ1RXcXFQaXI1NkVPMGJadmN6NWJKUFB2SmFyU21wR1U5T3JYejU4TkZkOVZ3WnVLaVA3UnhBZkpoSEhFN2pCMk5oNlY3VDdrY2FhMFdOYVBFTFlWNkFHYlV2eFBRb0FwLUt1QnhhaWxBSXJKMHVwWEhuQS1mNmxWWDNQN3duWlh4am9wZlBVbXlBMUdiTUlDaU9rZ0xqaU80TlhMLWZGVVJXYUd4RzFjTDNTRUhCRU1J?oc=5", "source_name": "SynBioBeta", "published_at": "2020-12-23T08:00:00+00:00", "published_display": "23 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RKDA Stock Price and Chart \u2014 NASDAQ:RKDA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5NTmNrZnJjZkJTY2NES1dZZ2hLejhST0lzMnpFVl84Wmh4bldEejZVTllUbHNZM3Z2UkNBRHdxdmpmTm8tRjVPTVRLRV9RanByZlN1QU82TWFrTDBu?oc=5", "source_name": "TradingView", "published_at": "2017-08-12T18:19:03+00:00", "published_display": "12 Aug 2017 18:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Arcadia Biosciences (RKDA) registers 11.9M resale shares from 2026 private placement", "summary": "Arcadia Biosciences is registering 11.9 million shares of common stock for resale by existing stockholders, which are issuable upon the exercise of pre-funded warrants, preferred investment options, and placement agent options from a private placement completed in June 2026. The ", "url": "https://www.stocktitan.net/sec-filings/RKDA/424b3-arcadia-biosciences-inc-prospectus-filed-pursuant-to-rule-424-b-14ba1909ac94.html", "source_name": "Stock Titan", "published_at": "2026-07-09T10:31:13", "published_display": "09 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Arcadia Biosciences, Inc. SEC Filing", "summary": "This article reports on an SEC filing by Arcadia Biosciences, Inc. (RKDA), detailing a Notice of Effectiveness for an S-3 form with an effectiveness date of July 8, 2026, at 5:00 P.M. The filing indicates a neutral impact and sentiment. The article also provides an overview of RK", "url": "https://www.stocktitan.net/sec-filings/RKDA/effect-arcadia-biosciences-inc-sec-filing-3a613fcdead2.html", "source_name": "Stock Titan", "published_at": "2026-07-09T10:31:13", "published_display": "09 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Arcadia Biosciences, Inc. \u2013 NASDAQ:RKDA", "summary": "The article focuses on the \"Price to sales forward\" metric for Arcadia Biosciences, Inc. (NASDAQ: RKDA). It is presented as a financial data point available on TradingView, within the company's financial overview. The content primarily highlights the financial metric without prov", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T18:40:12", "published_display": "04 Jul 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Arcadia Biosciences, Inc. \u2013 NASDAQ:RKDA", "summary": "This article displays the \"Price to earnings forward\" financial metric for Arcadia Biosciences, Inc. (NASDAQ: RKDA). It indicates that there are currently no trades and the market is closed for this stock. The content appears to be a stub or a placeholder from a financial data pl", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T09:10:54", "published_display": "04 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RKDA SEC Filings - Arcadia Bioscien 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Arcadia Biosciences (RKDA) SEC filings, including 10-K, 10-Q, and 8-K reports. It details recent material events such as the CFO's resignation and the CEO taking an interim finance role, as well as financial disclosures from Q2 2025", "url": "https://www.stocktitan.net/sec-filings/RKDA/page-3.html", "source_name": "Stock Titan", "published_at": "2026-07-04T06:09:55", "published_display": "04 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (FRA:17D) - Valuation Measures & Financial Statistics", "summary": "This article provides key valuation measures and financial statistics for Arcadia Biosciences Inc (FRA:17D) as of July 3. The company is currently operating at a loss with a P/B ratio of 0.52 and a market capitalization of \u20ac1.40M. It also highlights four severe warning signs dete", "url": "https://www.gurufocus.com/stock/DE00AZ/definition", "source_name": "GuruFocus", "published_at": "2026-07-04T05:10:54", "published_display": "04 Jul 2026 05:10", "sentiment": "negative", "sentiment_pct": 25, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences focuses on plant-based innovation for future growth", "summary": "Arcadia Biosciences is a biotechnology company focused on plant-based science for health, nutrition, and agriculture. The company aims to create long-term value through innovation in crops and plant-derived compounds, emphasizing intellectual property, strategic product developme", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/arcadia-biosciences-focuses-on-plant-based-innovation-for-future-growth/69680378", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T14:09:12", "published_display": "03 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences awards discretionary bonus to Thomas J. Schaefer", "summary": "Arcadia Biosciences approved a discretionary cash bonus for Thomas J. Schaefer, its CEO and Interim CFO, for his services in 2025. The bonus amount is $169,000, and it was approved by the Board and Compensation Committee. This announcement also noted the resignation of former CFO", "url": "https://www.tradingview.com/news/tradingview:1582148cf697c:0-arcadia-biosciences-awards-discretionary-bonus-to-thomas-j-schaefer/", "source_name": "TradingView", "published_at": "2026-07-02T20:40:32", "published_display": "02 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 58, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (NASDAQ: RKDA) grants CEO bonus and sets 2026 vote deadlines", "summary": "Arcadia Biosciences (NASDAQ: RKDA) has updated its executive compensation, awarding CEO Thomas J. Schaefer a discretionary cash bonus of $169,000 for 2025, bringing his total compensation to $473,058. The company also announced that its 2026 annual meeting of stockholders will be", "url": "https://www.stocktitan.net/sec-filings/RKDA/8-k-arcadia-biosciences-inc-reports-material-event-d9467e85dc6a.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:32", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences | 424B3: Prospectus", "summary": "This document is a 424B3 prospectus filing for Arcadia Biosciences. A prospectus is a formal legal document that is required by and filed with the SEC, providing details about an investment offering for sale to the public.", "url": "https://www.moomoo.com/news/notice/306473753/arcadia-biosciences-424b3-prospectus", "source_name": "Moomoo", "published_at": "2026-06-28T04:09:39", "published_display": "28 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-3 Arcadia Biosciences Inc For: 26 June", "summary": "This article announces the filing of Form S-3 by Arcadia Biosciences Inc. for June 26. It includes a standard Investing.com disclaimer about the high risks associated with trading financial instruments and cryptocurrencies, emphasizing that the data provided may not be real-time ", "url": "https://m.uk.investing.com/news/stock-market-news/form-s3-arcadia-biosciences-inc-for-26-june-93CH-4746945?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-27T04:09:21", "published_display": "27 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Arcadia Biosciences, Inc. \u2013 NASDAQ:RKDA", "summary": "This article displays the \"Enterprise value to revenue forward\" metric for Arcadia Biosciences, Inc. (NASDAQ: RKDA) on TradingView. It indicates that the market was closed at the time of viewing, with no trades activity. The content specifically highlights the financial metric fo", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:40:39", "published_display": "27 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) registers 11.9M shares for resale; options convertible", "summary": "Arcadia Biosciences (RKDA) has filed an S-3 registration statement for the resale of up to 11.9 million shares of common stock, which are issuable upon the exercise of pre-funded warrants, preferred investment options, and placement agent options. The company will not receive pro", "url": "https://www.stocktitan.net/sec-filings/RKDA/s-3-arcadia-biosciences-inc-shelf-registration-statement-91314cce39dc.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:40:39", "published_display": "26 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Actuals & Estimates (NASDAQ:RKDA)", "summary": "This article provides an overview of Arcadia Biosciences, Inc. (NASDAQ: RKDA) stock performance, financial actuals, and estimates. It covers current stock price, market capitalization, volatility, past earnings, and upcoming earnings reports, along with other financial metrics an", "url": "https://www.tradingview.com/symbols/NASDAQ-RKDA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:09:21", "published_display": "26 Jun 2026 15:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Actuals & Estimates (GETTEX:17D)", "summary": "This article provides an overview of Arcadia Biosciences, Inc. (GETTEX:17D), including its current stock price, market capitalization, and historical performance. It details financial actuals and estimates, such as earnings and revenue, and notes upcoming earnings report dates. T", "url": "https://www.tradingview.com/symbols/GETTEX-17D/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:39:38", "published_display": "25 Jun 2026 21:39", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Arcadia Biosciences Inc (RKDA) has a current financial score of 6.21, ranking 75 out of 95 in the Food & Tobacco industry, indicating a robust financial status despite low operating efficiency. The company's latest quarterly revenue was $1.10M, an 8.33% year-over-year decrease, a", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/financial-health", "source_name": "TradingKey", "published_at": "2026-06-23T09:39:29", "published_display": "23 Jun 2026 09:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Valuation: PE, PB & Fair Value Analysis", "summary": "Arcadia Biosciences Inc (RKDA) currently holds a valuation score of 8.65, placing it 37th out of 95 companies in the Food & Tobacco industry as of June 18, 2026. The company's P/E ratio is -0.14, which is significantly below its recent high and above its recent low. Key valuation", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-20T00:38:54", "published_display": "20 Jun 2026 00:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Arcadia Biosciences Inc (RKDA), detailing analyst ratings, price targets, and future revenue and EPS expectations. It notes that no earnings forecast score is currently available, but highlights a consensus \"Buy\" rating from one analy", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T13:09:09", "published_display": "19 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Arcadia Biosciences Inc (RKDA), highlighting its current price momentum score of 6.42 and identifying resistance at 1.56 and support at 0.38. Technical indicators, including MACD, RSI, and CCI, largely suggest a \"Sell\" signal, while a", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/technical", "source_name": "TradingKey", "published_at": "2026-06-19T11:09:09", "published_display": "19 Jun 2026 11:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Inc (RKDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Arcadia Biosciences Inc (RKDA), highlighting regional revenue contribution with specific figures for the United States at $4.86 million. It notes that relevant data for business segments, India, Canada, and Argentina have not yet been", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rkda/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T01:39:43", "published_display": "17 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "summary": "Arcadia Biosciences (RKDA) has announced a private placement totaling $4 million through the sale of common stock and preferred investment options. The offering, priced at-the-market under Nasdaq rules, is expected to close around June 12, 2026, with proceeds intended for working", "url": "https://www.globenewswire.com/news-release/2026/06/12/3310862/35730/en/arcadia-biosciences-rkda-announces-4-million-private-placement-priced-at-the-market-under-nasdaq-rules.html", "source_name": "GlobeNewswire", "published_at": "2026-06-16T04:39:41", "published_display": "16 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Raises ~$4 Million in Private Placement of Pre-Funded Warrants and Options", "summary": "Arcadia Biosciences announced a private placement raising approximately $4 million from an institutional accredited investor through the issuance of pre-funded warrants and Series A-1 and A-2 preferred investment options. The company also signed a registration rights agreement to", "url": "https://www.tradingview.com/news/tradingview:fc209fbef1708:0-arcadia-biosciences-raises-4-million-in-private-placement-of-pre-funded-warrants-and-options/", "source_name": "TradingView", "published_at": "2026-06-15T15:10:24", "published_display": "15 Jun 2026 15:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) completes $4M private placement with warrants and options", "summary": "Arcadia Biosciences (RKDA) has completed a $4 million private placement, issuing pre-funded warrants and Series A-1 and A-2 preferred investment options to an institutional accredited investor. The transaction, priced at $1.03 per unit under", "url": "https://www.stocktitan.net/sec-filings/RKDA/8-k-arcadia-biosciences-inc-reports-material-event-b5278ecbcc63.html", "source_name": "Stock Titan", "published_at": "2026-06-15T15:10:24", "published_display": "15 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million", "summary": "Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced a private placement aiming to raise around $4 million. The offering includes common stock and preferred stock options, with the proceeds intended for working capital and general corporate purposes. This strategic move is expected", "url": "https://www.moomoo.com/news/post/71455586/arcadia-biosciences-inc-announces-private-placement-of-common-stock-and", "source_name": "Moomoo", "published_at": "2026-06-15T07:09:36", "published_display": "15 Jun 2026 07:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "summary": "Arcadia Biosciences, Inc. (Nasdaq: RKDA) has announced the closing of a $4 million private placement. The placement involved the sale of common stock or pre-funded warrants, along with Series A-1 and A-2 preferred investment options, priced at $1.03 per share under Nasdaq rules, ", "url": "https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/arcadia-biosciences-rkda-announces-closing-of-4-million-private-placement-priced-at-the-market-under-nasdaq-rules/2364775", "source_name": "The Manila Times", "published_at": "2026-06-15T07:09:36", "published_display": "15 Jun 2026 07:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "summary": "Arcadia Biosciences (RKDA) announced a private placement of 4 million shares of its common stock to institutional investors, priced at $1.00 per share, resulting in gross proceeds of $4 million. The offering is expected to close around December 13, 2024, and the company plans to ", "url": "https://www.moomoo.com/news/post/71417410/press-release-arcadia-biosciences-rkda-announces-4-million-private-placement?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-14T09:41:05", "published_display": "14 Jun 2026 09:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences closes $4 million private placement By Investing.com", "summary": "Arcadia Biosciences (NASDAQ:RKDA) has completed a private placement, raising approximately $4 million in gross proceeds. The company sold nearly 3.9 million shares of common stock or pre-funded warrants at $1.03 per share, which is significant given its current market capitalizat", "url": "https://ng.investing.com/news/stock-market-news/arcadia-biosciences-closes-4-million-private-placement-93CH-2557065", "source_name": "Investing.com Nigeria", "published_at": "2026-06-13T10:39:27", "published_display": "13 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOTFNWQlkxdkJKWS0xXzJpaTJqbTZOQUctVGVBVTF3cGRLRS1JTHR2YlFubHlyMGVibURDQWt4Rm8yWWxYVVQzcklCNFMwVlpjOURIZy1xR1MxNnJOSHlQRVU3ZXRuekk2UW1lcVhCdlJMbldvR1R5VzRrcDBoZlRFcEJyVjVKbVljNk1YRTVLTXI5UWZiR0NOZXczcWEzQUlrTTJ0QzZuN2o5d3ktY0dqY1RsS0JpeHAzZDdPNzNWQkk4LWdxcHB1RldTU0tSOV92ODByYjZZUHdRZHFfYzhmNg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences raises $4M in at-the-market stock deal", "summary": "Arcadia Biosciences (Nasdaq: RKDA) has closed a $4 million private placement, selling 3,883,496 common shares (or pre-funded warrants) and associated Series A-1 and A-2 preferred investment options at $1.03 per share. The net proceeds will be used for working capital and general ", "url": "https://www.stocktitan.net/news/RKDA/arcadia-biosciences-rkda-announces-closing-of-4-million-private-rviky4ef2bfc.html", "source_name": "Stock Titan", "published_at": "2026-06-13T02:10:15", "published_display": "13 Jun 2026 02:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences Raises $4 Million in Private Placement", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/arcadia-biosciences-raises-4-million-072643946.html", "source_name": "MT Newswires", "published_at": "2026-06-12T07:26:43+00:00", "published_display": "12 Jun 2026 07:26", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences raises $4 million in private placement By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNSGVPQ2J6VTUtZTA0OXlFSGtKM1hFUGU2NHpON1BhNmNocnE4ZW9YaDY3ck1JRFZnZnNmWHUtZ0dQY01wdFkyY3FzZVVaRkxzS09aTThYQ1VZbXJYZUhiTVBJUTNpZGtQZkJZRFdld2xPSGUyTDBXc2pmWWRqVmVveFJSUkhrci0xV2MyOWVwZkIwaWdzdmNwWDI3V01BTkd4MlhQYkRsci1VNHRiZnVRMGhVY2QtWkxURHc?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-06-12T00:40:55+00:00", "published_display": "12 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wellness products maker Arcadia Biosciences lines up $4M in funding", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQaFhyRVY5V1paRlhRTnB6UFgzd1BMMmpxem5mZ1EteHV2T0M5MUpoSHZlblNKNUV4cnJGTFVBMldDSnFYNW9NcUFuT2VjaVVWSUpXcHk2cFowSVJpdnBfTm1mVFgxSlZoWHlZTVk4WVFCN3U3bmpzRllLY1RSRE94T2dzLUNkWll6SDQ4YTJzSG9HTDBCaFZRLXlLM2FyT2NKTlktbFp3aEFYRlZzWXhxVXVJZFBRcThV?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences stock (US03020Q1058): pipeline update and strategic shift keep investors watchin", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOX0Z2c0NlYm9sM1RPTFFUZVNLWS1fcmJGTkpGOTlGaU5LeUQ1TmMzOHhSQzNjX2ZvS2ZKZk5qcXZLYjU2c29vemk3dmR1SjJuWUtRSGtFRndEMWEzZktiY3RWLXRBS3I1dnktS2FWeG1tYlc2ekNkTS1TcnVMR01JM0pTTGt2V3Q4Q2RoOHE5UTBzOWU2WWI2WHdSUG9wNW5vWnBpdFVTYm0tZG45b1VtMzJaNVh2ZTJHbWNRS3I0VjJIVFlTd3c?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/arcadia-biosciences-q1-earnings-snapshot-230843698.html", "source_name": "Associated Press", "published_at": "2026-05-14T23:08:43+00:00", "published_display": "14 May 2026 23:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxPcmU1OVdFZERha0pSdnh3Q0NhNG1HX3Y0TjR3UnRsMnBFMUF5ZU1JMU85emROc2YwRHVEWFV6Y1RoY1cwWVNaNEtRN0prUkxuV2E2UjdKdUZQY2tyOFBNSW4tVnBPNGxqemc4ODJaY1Nyc1Q0Wm9VN2VPSUctbXJCUGZOeEJEWTkzSGJoOUZJVVByc0UtSDRWUUVkU1NRQVJfa1R2bk1vZmlQbzNEVHk5c0lOSDRqODE0V3pHc09PQWRIZ196M1NNWnNFNklEN0RQRlBtQzFjZ0xlX2lpMnVWbFdmVy1lNlBqWjliOVBqQkNaV1VlQmRQdVBtWQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Bioscien (RKDA) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFB6bFZRQjRkcG1rODZxeFY0ZVk3UmdHVlJCWGJrYVRWTE1WMTRjSm4xRmY2UXVTQ3llY1gxQlQyNW5BOWQwQS1lOVVSenB1UQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxQNS0yVnF0QnhXZ3RCbVpIamlub3RiRjdrSl9Nc2Z2Q3FqY1c3QWpzTjhYdUEyM2tKUTM2NFZPdUoxRV8tU1JodzRjR3RqYlRuRkdiN1dYSXZoanBUUndFb2pzX1c2U19DYUhCMHF0N20yS1ZFYUNUTDhjXzRzTlZnSEJlWmphd3JoeUFnckdQd3dWcW1kcDBBU3JtLURVVnJDVEJERHFpNURzY0tveFctTVM0UFdtSXhZMXFSMFNHSTNyTzB1RFBZTjAxN1lfZ1oxVFpTSFRpeTgwZ3RBUkVUZmR6ZllucHkwazFYaGpmZGRmenpIRG1ZVEJPMHEtVFNKSC1saw?oc=5", "source_name": "Business Wire", "published_at": "2024-12-05T08:00:00+00:00", "published_display": "05 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arcadia Biosciences (RKDA) Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOdS04bXkyZjFid1hiVjZsRXVwVnJDSjF4RFZWQ1RXcXFQaXI1NkVPMGJadmN6NWJKUFB2SmFyU21wR1U5T3JYejU4TkZkOVZ3WnVLaVA3UnhBZkpoSEhFN2pCMk5oNlY3VDdrY2FhMFdOYVBFTFlWNkFHYlV2eFBRb0FwLUt1QnhhaWxBSXJKMHVwWEhuQS1mNmxWWDNQN3duWlh4am9wZlBVbXlBMUdiTUlDaU9rZ0xqaU80TlhMLWZGVVJXYUd4RzFjTDNTRUhCRU1J?oc=5", "source_name": "SynBioBeta", "published_at": "2020-12-23T08:00:00+00:00", "published_display": "23 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RKDA Stock Price and Chart \u2014 NASDAQ:RKDA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5NTmNrZnJjZkJTY2NES1dZZ2hLejhST0lzMnpFVl84Wmh4bldEejZVTllUbHNZM3Z2UkNBRHdxdmpmTm8tRjVPTVRLRV9RanByZlN1QU82TWFrTDBu?oc=5", "source_name": "TradingView", "published_at": "2017-08-12T18:19:03+00:00", "published_display": "12 Aug 2017 18:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 39, "sentiment_summary": {"positive": 9, "negative": 6, "neutral": 24, "score": 50, "total": 39, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 14.85, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 5.3, "count": 9}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 9, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 0.68, "latest_week": "2026-07-10", "one_week_move": -6.6, "four_week_move": -33.5, "twelve_week_move": -42.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.521354, "market_dynamics_buy_signal": false, "relative_strength": -77.785384, "fair_value_gap": -78.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 43.1311, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.6% over one week, -33.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 9}, {"label": "TradingView", "count": 8}, {"label": "TradingKey", "count": 5}, {"label": "Moomoo", "count": 3}, {"label": "GlobeNewswire", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "GuruFocus", "count": 1}, {"label": "Ad-hoc-news.de", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 39}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 9}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "39", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.6% over one week, -33.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Arcadia Biosciences (RKDA) registers 11.9M resale shares from 2026 private placement"}], "updated_at": "2026-07-16T11:59:36.454776+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}